Katya Galactionova

Katya Galactionova is a skilled professional in health economics and modeling, currently serving as the Global Access Evidence (Analysis) Lead at Roche, where they develop health-economic evidence to support drug reimbursement. Previously, Katya was a Senior Research Scientist at the European Center of Pharmaceutical Medicine, leading economic evaluations and modeling of health interventions. They also served as a Senior Scientific Collaborator at the Swiss Tropical and Public Health Institute, where they performed data analysis and simulations related to infectious disease interventions. Katya earned a PhD in Epidemiology and Public Health from the University of Basel and holds a Master's degree in Applied Economics from the University of North Carolina at Greensboro.